10 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaNeoplasms by Site, Skin and Connective Tissue Diseases, neoplasm, skin disorder, skin neoplasmRecruitingPhase 32026-09-16NCT06585410
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackAcute Myocardial Infarction (AMI); Cardiovascular RiskActive, not recruitingPhase 32026-09-09NCT06118281
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1HIV-1-infectionRecruitingPhase 22026-09-04NCT07645287
A Study of DR-01 in Subjects With Alopecia Areata and VitiligoPathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypopigmentation of the skin, hypotrichosis, skin disorder, skin pigmentation disorder, vitiligoActive, not recruitingPhase 12026-07-08NCT06602232
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyHIV-1-infectionActive, not recruitingPhase 32026-06-15NCT06333808
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous FatSubcutaneous FatRecruitingPhase 22026-06-04NCT07608770
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous FatSubcutaneous FatNot yet recruitingPhase 22026-05-29NCT07608757
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1HIV-1-InfectionActive, not recruitingPhase 32026-05-29NCT06630299
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1HIV-1-infectionActive, not recruitingPhase 32026-04-30NCT06630286
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorderRecruitingPhase 12025-11-20NCT07205159